What is Cell Sciences?
Cell Sciences specializes in offering a comprehensive portfolio of high-quality biochemical reagents, including proteins, peptides, antibodies, and immunoassay kits. These products are critical for research projects involving human, non-human primate, and various animal models globally. The company's commitment to enhancing research efficiency and accuracy is evident in its offerings, which include advanced ELISA kits, biologically active antibodies, and reference tissues. Notably, Cell Sciences also provides specialized tools for SARS-CoV-2 research, demonstrating its adaptability to emerging scientific needs.
How much funding has Cell Sciences raised?
Cell Sciences has raised a total of $90K across 1 funding round:
Debt
$90K
Debt (2021): $90K with participation from PPP
Key Investors in Cell Sciences
PPP
Public-Private Partnership
What's next for Cell Sciences?
Operating at a significant Series B/C stage, Cell Sciences is poised for accelerated growth and market penetration. The recent influx of expansion capital is expected to fuel strategic initiatives, potentially including the scaling of production capabilities, enhancement of its product development pipeline, and broader market outreach. This investment signifies strong investor confidence in Cell Sciences' business model and its capacity to meet the growing demands of the global life science research community.
See full Cell Sciences company page
